AVANOS MEDICAL, INC. (NYSE:AVNS) Shares Acquired by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC boosted its position in shares of AVANOS MEDICAL, INC. (NYSE:AVNS - Free Report) by 106.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 128,059 shares of the company's stock after buying an additional 65,930 shares during the period. Rice Hall James & Associates LLC owned 0.28% of AVANOS MEDICAL worth $1,835,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in AVNS. GAMMA Investing LLC lifted its holdings in shares of AVANOS MEDICAL by 2,381.6% during the first quarter. GAMMA Investing LLC now owns 17,024 shares of the company's stock worth $244,000 after purchasing an additional 16,338 shares during the period. Bank of America Corp DE lifted its stake in shares of AVANOS MEDICAL by 2.5% in the 4th quarter. Bank of America Corp DE now owns 63,672 shares of the company's stock worth $1,014,000 after acquiring an additional 1,537 shares during the period. Envestnet Asset Management Inc. boosted its holdings in shares of AVANOS MEDICAL by 15.8% in the fourth quarter. Envestnet Asset Management Inc. now owns 128,567 shares of the company's stock valued at $2,047,000 after acquiring an additional 17,504 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of AVANOS MEDICAL by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 5,339,778 shares of the company's stock worth $85,009,000 after acquiring an additional 19,476 shares during the period. Finally, SG Americas Securities LLC acquired a new position in AVANOS MEDICAL during the 1st quarter worth approximately $344,000. Hedge funds and other institutional investors own 95.17% of the company's stock.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded AVANOS MEDICAL from a "hold" rating to a "buy" rating in a research report on Wednesday, March 19th.

AVANOS MEDICAL Trading Down 0.7%

Shares of NYSE:AVNS traded down $0.08 during trading on Wednesday, reaching $11.46. The stock had a trading volume of 657,459 shares, compared to its average volume of 390,209. The company has a quick ratio of 1.56, a current ratio of 2.57 and a debt-to-equity ratio of 0.12. The stock has a market cap of $529.86 million, a P/E ratio of -1.37 and a beta of 1.12. The business has a fifty day moving average price of $12.37 and a 200-day moving average price of $13.93. AVANOS MEDICAL, INC. has a fifty-two week low of $11.21 and a fifty-two week high of $25.36.

AVANOS MEDICAL (NYSE:AVNS - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 EPS for the quarter, beating analysts' consensus estimates of $0.19 by $0.07. AVANOS MEDICAL had a negative net margin of 55.80% and a positive return on equity of 6.26%. The company had revenue of $167.50 million during the quarter, compared to the consensus estimate of $161.75 million. During the same quarter in the prior year, the company posted $0.22 EPS. The company's quarterly revenue was up .8% compared to the same quarter last year. As a group, analysts anticipate that AVANOS MEDICAL, INC. will post 1.32 earnings per share for the current fiscal year.

About AVANOS MEDICAL

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.